Exact Mass: 572.206
Exact Mass Matches: 572.206
Found 94 metabolites which its exact mass value is equals to given mass value 572.206
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
chiglitazar
Letermovir
4-[(2-{Bis[(pyridin-2-YL)methyl]amino}ethyl)amino]-2-(6-hydroxy-3-oxo-3H-xanthen-9-YL)benzoic acid
3-(3-Hydroxy-2,4-dimethoxyphenyl)-4-[5-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)-4-hydroxy-2-methoxyphenyl]-7-hydroxy-3,4-dihydro-2H-1-benzopyran
15-O-beta-D-glucipyranosyl-21-hydroxyglaucarubolone
(S)-7-O-methylpeucedanol 3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
3,4-dehydro-5(S)-5-carboxystrictosidine|3,4-dehydro-5-carboxystrictosidine
(18R)-17,18-epoxy-18-beta-D-glucopyranosyloxy-21beta-hydroxy-(20alphaH)-21a-homo-19-nor-coryn-16-ene-5beta,16-dicarboxylic acid 5-lactone 16-methyl ester|19alpha-beta-D-glucopyranosyloxy-21beta-hydroxy-(20alpha)-18-oxa-21a-homo-yohimb-16-ene-5beta,16-dicarboxylic acid 5-lactone 16-methyl ester|Rubenin (1a)|rubenine
5-Methoxy-(3R,4S,3S)-4-(6,7-Dihydroxy-4-methoxyisoflavan-3-yl)-2,7-dihydroxy-4-methoxyisoflavan
3-(2-Hydroxy-4,5-dimethoxyphenyl)-4-[5-(7-hydroxy-3,4-dihydro-2H-1-benzopyran-3-yl)-4-hydroxy-2-methoxyphenyl]-7-hydroxy-3,4-dihydro-2H-1-benzopyran
3-Hydroxy,2-Me ether-(3R,4S,3S)-4-(6,7-Dihydroxy-4-methoxyisoflavan-3-yl)-2,7-dihydroxy-4-methoxyisoflavan
Asp Glu Phe Tyr
Asp Glu Tyr Phe
Asp Phe Glu Tyr
Asp Phe Tyr Glu
Asp Tyr Glu Phe
Asp Tyr Phe Glu
Glu Asp Phe Tyr
Glu Asp Tyr Phe
Glu Phe Asp Tyr
Glu Phe Tyr Asp
Glu Met Met Tyr
Glu Met Tyr Met
Glu Tyr Asp Phe
Glu Tyr Phe Asp
Glu Tyr Met Met
Phe Asp Glu Tyr
Phe Asp Tyr Glu
Phe Glu Asp Tyr
Phe Glu Tyr Asp
Phe Tyr Asp Glu
Phe Tyr Glu Asp
Met Glu Met Tyr
Met Glu Tyr Met
Met Met Glu Tyr
Met Met Tyr Glu
Met Tyr Glu Met
Met Tyr Met Glu
Tyr Asp Glu Phe
Tyr Asp Phe Glu
Tyr Glu Asp Phe
Tyr Glu Phe Asp
Tyr Glu Met Met
Tyr Phe Asp Glu
Tyr Phe Glu Asp
Tyr Met Glu Met
Tyr Met Met Glu
allylchloro[1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium (ii)
4-[2-[bis(pyridin-2-ylmethyl)amino]ethylamino]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
(4S)-3-{(2R,5R)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanoyl}-4-phenyl-1,3-oxazolidin-2-one
Letermovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
Carfloglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-
(2S)-2-[[(4S)-4-[[4-[(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid
sodium;(2S)-2-[[(2S)-2-[(1-ethoxycarbonylpiperidin-4-yl)oxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonate
5-[(3R,3R,4S,5R)-4-[fluoro(dimethyl)silyl]-5-(2-hydroxyethyl)-3-methyl-2-oxo-1-prop-2-enyl-5-spiro[indole-3,2-oxolane]yl]-6-benzo[b][1,4]benzoxazepinone
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(2S,3R)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-pyrazinecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methylbenzenesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-phenylmethanesulfonamide
2-[2,6-Dihydroxy-4-[6-hydroxy-7-(3-methylbut-2-enyl)-1-benzouran-2-yl]phenyl]-4-methyl-6-(2,4,5-trihydroxyphenyl)cyclohex-3-ene-1-carboxylic acid
2-[2,6-Dihydroxy-4-[6-hydroxy-7-(3-methylbut-2-enyl)-1-benzouran-2-yl]phenyl]-6-(2,4-dihydroxyphenyl)-5-hydroxy-4-methylcyclohex-3-ene-1-carboxylic acid
2-[2,6-dihydroxy-4-[6-hydroxy-7-[(E)-4-hydroxy-3-methylbut-2-enyl]-1-benzouran-2-yl]phenyl]-6-(2,4-dihydroxyphenyl)-4-methylcyclohex-3-ene-1-carboxylic acid
4-O-methylrhodomycin D(1+)
An organic cation that is the conjugate acid of 4-O-methylrhodomycin D, obtained by protonation of the amino group; major species at pH 7.3.
Chiglitazar
Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
3-(3-hydroxy-2,4-dimethoxyphenyl)-4-[4-hydroxy-5-(7-hydroxy-3,4-dihydro-2h-1-benzopyran-3-yl)-2-methoxyphenyl]-3,4-dihydro-2h-1-benzopyran-7-ol
4,5,17-trihydroxy-6-(hydroxymethyl)-14,18-dimethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-ene-9,16-dione
4-(6',7-dihydroxy-4'-methoxyisoflavan-3'-yl)-2',7-dihydroxy-4'-methoxyisoflavan; (3r,4s,3''s)-form,3'-hydroxy,2'-me ether
{"Ingredient_id": "HBIN010058","Ingredient_name": "4-(6',7-dihydroxy-4'-methoxyisoflavan-3'-yl)-2',7-dihydroxy-4'-methoxyisoflavan; (3r,4s,3''s)-form,3'-hydroxy,2'-me ether","Alias": "NA","Ingredient_formula": "C33H32O9","Ingredient_Smile": "NA","Ingredient_weight": "572.6","OB_score": "NA","CAS_id": "100478-01-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7960","PubChem_id": "NA","DrugBank_id": "NA"}